We invest in innovative technologies ‘beyond the pill’. @COPDFoundation says Novartis comes across as very thoughtful in what they do in the technology space. See our Materiality Assessment Results Report to understand our commitment. t.co/3iLCziQUl9#ERSCongresst.co/dDsbLCr62S